So when I started work in TB, the treatment for DRTB was 2years, costed thousands of dollars and less than 50% of people were cured. I was involved in a meeting to dream of future of the treatment for people with DRTB. Now it seems that that dream is coming true. #WHO
guidance on all oral 6 month regimen (https://bit.ly/3W3ilNz) that are cost effective (https://bit.ly/3YG76wn) and are supported by
#GlobalFund
(https://bit.ly/3j7HCaT). What a lovely way to end the year! Let's hope that in 2023, countries start scaling up this regimen that cures more than 85% of people.

Want to know some of the work that #Globalfund supports for #TB? The latest quarterly update is out and includes updates on case finding activities from Nigeria and Viet Nam. Read to find out more about how Nigeria increased their TB case detection by 50% from 138,591 in 2020 to 207,785 TB cases in 2021 - really impressive work! https://bit.ly/3EzhY5Q

Gender and #TB is a complex issue with different challenges for access and outcomes for men and women. Join the discussion tomorrow with #WHO and #TheUnion to discuss
Multisectoral engagement to improve gender equity in TB and ensure no one is left behind. I will be presenting on the role of #Globalfund on investing in Gender equity for TB. https://www.who.int/news-room/events/detail/2022/11/21/default-calendar/international-men-s-day--2022multisectoral-engagement-to-improve-gender-equity-in-tb-and-ensure-no-one-is-left-behind